The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

Published:2020-07-02 Issue:1 Volume:15 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Glavind Emilie^ORCID,Gotthardt Daniel N.,Pfeiffenberger Jan,Sandahl Thomas Damgaard,Bashlekova Teodora,Willemoe Gro Linno,Hasselby Jane Preuss,Weiss Karl Heinz,Møller Holger Jon,Vilstrup Hendrik,Lee William M.,Schilsky Michael L.,Ott Peter,Grønbæk Henning

Funder

AbbVie

Intercept

Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat

Novo Nordisk Fonden

The Memorial Foundation of Manufacturer Vilhelm Petersen & Wife

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-020-01452-2.pdf

Reference36 articles.

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet. 2007;369(9559):397–408.

2. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology (Baltimore, Md). 2008;47(6):2089–111.

3. Clinical Practice Guidelines EASL. Wilson’s disease. J Hepatol. 2012;56(3):671–85.

4. Ferenci P. Whom and how to screen for Wilson disease. Expert Rev Gastroenterol Hepatol. 2014;8(5):513–20.

5. Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011;140(4):1189–98.e1.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Circulating Markers of Microbial Translocation and Hepatic Inflammation with Liver Injury in Patients with Type 2 Diabetes;Biomedicines;2024-05-31

2. Future directions in acute liver failure;Hepatology;2023-05-16

3. Acute Liver Failure: Biomarkers Evaluated by the Acute Liver Failure Study Group;Clinical and Translational Gastroenterology;2023-01-25

4. Hematogenous Macrophages: A New Therapeutic Target for Spinal Cord Injury;Frontiers in Cell and Developmental Biology;2021-11-24

5. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge;World Journal of Hepatology;2021-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3